IL6 and neuroblastoma: MYCN expression in NB cells alters the angiogenic balance by downregulating EC growth inhibitors such as leukemia inhibitory factor (LIF), IL-6 and Activin A, but leaving the expression of the stimulators unaffected [53,54].